Organization | Medical University of Warsaw

Medical University of Warsaw Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Warsaw Poland (1950)

Organization Overview

First Clinical Trial

2004

NCT00565123

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

1st Chair and Department of Cardiology, Medical University of Warsaw | 1st Department of Cardiology Medical University of Warsaw | Center of Oncology, Warsaw, Poland | Department of Hematology, Oncology and Internal Diseases, the Medical University of Warsaw | Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw | Department of Pediatric Diabetology and Pediatrics, Pediatric Teaching Clinical Hospital of the Medical University of Warsaw, Poland | Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw | Department of Pediatrics, Medical University of Warsaw | Department of Pediatrics, Medical University of Warsaw, Poland | Department of Pediatrics of the Medical University of Warsaw | Department of Pediatrics, Warsaw Medical University | Gen. Surgery, Vascular and Transplantation Dept., Medical University of Warsaw | I Department of Anaesthesiology and Intensive Care, Infant Jesus Teaching Hospital | Laser Microsurgery Centre; Department of Ophthalmology, Medical University of Warsaw | Life Clinic | Medical Univeristy of Warsaw | Medical University of Warsaw | Medical University of Warsaw, Child and Adolescent Psychiatry Department | Medical University of Warsaw, Department of General, Transplant and Liver Surgery | Medical University of Warsaw, Dept of General, Vascular and Transplant Surgery | Medical University of Warsaw, Poland | National Institute of Cardiology, Department of Coronary Artery Disease - Warsaw - POLAND | National Institute of Cardiology, Warsaw | Pediatric Department of St. Hedwig of Silesia Hospital | The Department of Pediatrics with Clinical Assessment Unit, The Medical University of Warsaw | The Medical Centre for Postgraduate Education, and Center of Oncology Institute, Warsaw, Poland | The Medical University of Warsaw | The Medical University of Warsaw; Poland | The Medical Univ of Warsaw, Dept of Paediatrics | University Health Center of Woman and Child, Medical University of Warsaw | Warsaw Medical University, Department of Neonatology | Warsaw Medical University Hospital, Department of Neonatology and Intensive Care Unit | Warszawski Uniwersytet Medyczny

Active Ingredients

Drugs in Phase 4 Trials (37)

acetylsalicylic acid (aspirin) (2 trials)

azathioprine (imuran) (1 trial)

benzodiazepine (1 trial)

bifidobacterium animalis (1 trial)

bisacodyl (Halflytely) (1 trial)

clopidogrel (plavix) (2 trials)

dabigatran (pradaxa) (1 trial)

dexmedetomidine (precedex) (2 trials)

fentanyl (Innovar) (4 trials)

ferrous sulfate (1 trial)

furosemide (lasix) (1 trial)

glucomannan (3 trials)

insulin aspart (novolog) (3 trials)

insulin glulisine (Apidra) (5 trials)

insulin lispro (humalog) (5 trials)

ivabradine (corlanor) (1 trial)

ketamine (ketalar) (2 trials)

lactobacillus casei rhamnosus lcr35 (1 trial)

lactobacillus reuteri (5 trials)

lactobacillus rhamnosus (6 trials)

levobupivacaine (chirocaine) (2 trials)

lidocaine (xylocaine) (4 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

methylprednisolone (medrol) (1 trial)

midazolam (versed) (1 trial)

natrium chloratum (1 trial)

polyethylene glycol (2 trials)

prednisone (meticorten) (1 trial)

protamine sulfate (1 trial)

remifentanil (ultiva) (1 trial)

sennosides a&b (1 trial)

sodium chloride (2 trials)

sufentanil (1 trial)

ticagrelor (brilinta) (2 trials)

torsemide (demadex) (1 trial)

tramadol (Ultram) (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (5)

human fecal microbiota (Reybota) (3 trials)

levofloxacin (levaquin) (1 trial)

macrogol 4000 (1 trial)

maltodextrin (3 trials)

prunus domestica extract (1 trial)

Drugs in Phase 2 Trials (13)

177lu-dotatoc (1 trial)

autologous adipose-derived mesenchymal stem cells (3 trials)

bovine lactoferrin (1 trial)

empagliflozin (jardiance) (1 trial)

etanercept (enbrel) (1 trial)

icosapent ethyl (vascepa) (1 trial)

insulin human (humulin) (1 trial)

istaroxime (1 trial)

pleuran (1 trial)

vegf-a165/bfgf (1 trial)

vitamin c (1 trial)

wharton's jelly mesenchymal stem cells (1 trial)

ω-6 fatty acids (1 trial)

Drugs in Phase 1 Trials (4)

allogeneic adipose derived mesenchymal stem cell (1 trial)

gelatin tannate (1 trial)

ribavirin (virazole) (1 trial)

sd-101 (1 trial)

Drugs in Other Trials (20)

bifidobacterium bifidum (1 trial)

bifidobacterium infantis (1 trial)

bifidobacterium lactis (1 trial)

cefuroxime (zinacef) (1 trial)

cholera vaccine (Vaxchora) (1 trial)

ephedrine (1 trial)

inactivated influenza vaccine (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus paracasei (1 trial)

lactobacillus plantarum (2 trials)

lactobacillus salivarius (1 trial)

morphine (2 trials)

oligofructose (1 trial)

oxygen (1 trial)

peanut (1 trial)

peanut allergen (1 trial)

phenylephrine (Prefrin) (1 trial)

tacrolimus (prograf) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abdominal Pain (Phase 4)

Acute Coronary Syndrome (Phase 4)

Acute Pain (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 1)

Anemia, Iron-Deficiency (Phase 4)

Aortic Valve Stenosis (Phase 4)

Appendicitis (Phase 4)

Atrial Fibrillation (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 2)

Blister (Phase 4)

Body Weight (Phase 1)

Cardiomyopathies (Phase 4)

Chemical and Drug Induced Liver Injury (Phase 4)

Cicatrix (Phase 2)

Cognitive Dysfunction (Phase 4)

Colic (Phase 3)

Communicable Diseases (Phase 4)

Conjunctivitis (Phase 3)

Conjunctivitis, Bacterial (Phase 3)

Constipation (Phase 4)

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Cross Infection (Phase 3)

Cutis Laxa (Phase 2)

Diabetes Insipidus (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetic Foot (Phase 2)

Diarrhea (Phase 4)

Digestive System Diseases (Phase 4)

Eye Diseases (Phase 4)

Foot Ulcer (Phase 2)

Fractures, Bone (Phase 4)

Gastroenteritis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Gastrointestinal Diseases (Phase 4)

Gastrointestinal Hemorrhage (Phase 4)

Graves Disease (Phase 4)

Graves Ophthalmopathy (Phase 4)

Heart Failure (Phase 4)

Hemorrhage (Phase 4)

Hepatic Insufficiency (Phase 4)

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis C (Phase 1)

Hepatitis C, Chronic (Phase 1)

Hepatitis, Chronic (Phase 1)

Hyaline Membrane Disease (Phase 1)

Hyperkinesis (Phase 2)

Hypothermia (Phase 2)

Infarction (Phase 4)

Infections (Phase 4)

Ischemia (Phase 2)

Labor Pain (Phase 4)

Liver Diseases (Phase 4)

Liver Failure (Phase 4)

Liver Failure, Acute (Phase 4)

Motor Neuron Disease (Phase 1)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 2)

Myocarditis (Phase 4)

Neuroendocrine Tumors (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Hip (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overweight (Phase 1)

Pain, Postoperative (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Reperfusion Injury (Phase 2)

Respiratory Distress Syndrome (Phase 1)

Respiratory Distress Syndrome, Newborn (Phase 1)

Respiratory Tract Infections (Phase 4)

Syndrome (Phase 4)

Urinary Bladder Neoplasms (Phase 4)

Vomiting (Phase 4)

Wounds and Injuries (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 78
# of Trial APIs: 79